I agree that this site is using cookies. You can find further informations here.
X
Chiarion Sileni, Vanna
299  results:
Search for persons X
?
1

Italian nivolumab Expanded Access Programme in melanoma adj..:

Ascierto, Paolo A. ; Di Giacomo, Anna M. ; Chiarion Sileni, Vanna...
European Journal of Cancer.  191 (2023)  - p. 113246 , 2023
Link: https://doi.org/10.1016/..
 
?
2

The Pattern of Progression to First-Line Treatment with Dab..:

Del Vecchio, Michele ; Chiarion Sileni, Vanna ; Quaglino, Pietro...
Cancers.  15 (2023)  7 - p. 1980 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Basal and one-month differed neutrophil, lymphocyte and pla..:

Guida, Michele ; Bartolomeo, Nicola ; Quaresmini, Davide...
Journal of Translational Medicine.  20 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
4

Corrigendum to 'Quality of life in patients with BRAF-mutan..:

Gogas, Helen ; Dummer, Reinhard ; Ascierto, Paolo A....
European Journal of Cancer.  160 (2022)  - p. 287-288 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Avelumab expanded access program in metastatic Merkel cell ..:

Ascierto, Paolo Antonio ; Orlova, Kristina ; Grignani, Giovanni...
International Journal of Cancer.  149 (2021)  11 - p. 1926-1934 , 2021
Link: https://doi.org/10.1002/..
 
?
6

Avelumab treatment in Italian patients with metastatic Merk..:

Grignani, Giovanni ; Chiarion Sileni, Vanna ; Pinto, Carmine...
Journal of Translational Medicine.  19 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
7

Corrigendum: Melanoma of Unknown Primary: Evaluation of the..:

Del Fiore, Paolo ; Rastrelli, Marco ; Dall'Olmo, Luigi...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
8

A Therapeutic and Diagnostic Multidisciplinary Pathway for ..:

Rastrelli, Marco ; Del Fiore, Paolo ; Buja, Alessandra...
Frontiers in Oncology.  10 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
9

Prognostic impact of regression in patients with primary cu..:

Ribero, Simone ; Galli, Francesca ; Osella-Abate, Simona...
Journal of the American Academy of Dermatology.  80 (2019)  1 - p. 99-105.e5 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Cutaneous Side Effects of Targeted Therapy and Immunotherap..:

Russo, Irene ; Zorzetto, Ludovica ; Chiarion Sileni, Vanna.
Scientifica.  2018 (2018)  - p. 1-7 , 2018
Link: https://doi.org/10.1155/..
 
?
11

Prognostic Factors in Merkel Cell Carcinoma: A Retrospectiv..:

Rastrelli, Marco ; Ferrazzi, Beatrice ; Cavallin, Francesco...
Cancers.  10 (2018)  10 - p. 350 , 2018
Link: https://doi.org/10.3390/..
 
?
12

Open-label, multicentre safety study of vemurafenib in 3219..:

Blank, Christian U. ; Larkin, James ; Arance, Ana M....
European Journal of Cancer.  79 (2017)  - p. 176-184 , 2017
Link: https://doi.org/10.1016/..
 
?
13

A comparative study of the cutaneous side effects between B..:

Russo, Irene ; Zorzetto, Ludovica ; Frigo, Anna Chiara..
European Journal of Dermatology.  27 (2017)  5 - p. 482-486 , 2017
Link: https://doi.org/10.1684/..
 
?
14

Efficacy and safety of ipilimumab in elderly patients with ..:

Chiarion Sileni, Vanna ; Pigozzo, Jacopo ; Ascierto, Paolo Antonio...
Journal of Experimental & Clinical Cancer Research.  33 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
15

Efficacy and safety of ipilimumab in patients with advanced..:

Queirolo, Paola ; Spagnolo, Francesco ; Ascierto, Paolo Antonio...
Journal of Neuro-Oncology.  118 (2014)  1 - p. 109-116 , 2014
Link: https://doi.org/10.1007/..
 
1-15